Webabrysvo r is a new vaccine approved by health canada for the prevention of lower respiratory tract disease (lrtd) caused by rsv in people 60 years of age and older.

In june 2023, centers for disease control and prevention (cdc) recommended the rsv vaccination for adults 60 or older.

The cdc recommends that the following adults should get one dose of the respiratory syncytial virus (rsv) vaccine to provide protection against serious rsv illness.

Recommended for you

This is for adults who have not already received an rsv.

Webyes, the rsv vaccine protects the body from rsv.

Webhealth canada has approved the first vaccine for respiratory syncytial virus (rsv) for adults age 60 and over, but it may only be available in limited quantities for.

Plus, get a $5 off $20.

You may also like